TipRanks
Go Ultimate55% OFF

David Shook Insider Profile

11 Followers

David Shook, CMO at Lyell Immunopharma, holds 20.42K shares in Lyell Immunopharma (Ticker: LYEL), holds 190.96K shares in Nkarta (Ticker: NKTX). Most recently, David Shook Sold ― shares of Lyell Immunopharma on Sep 10, 2026 for an estimated value of $6.35K.

David Shook's Trading History

LYEL
Lyell Immunopharma
Sep 10, 2026CMOInformative Sell6.35K$225.47K
NKTX
Nkarta
Jan 17, 2025Chief Medical Officer, Head of Research & DevelopmentInformative Sell19.00K$297.89K

You May Also Like

David Shook insider profile FAQ

What is the percentage of profitable transactions made by David Shook?
The percentage of profitable transactions made by David Shook is 67%.
What is the average return per transaction made by David Shook?
The average return per transaction made by David Shook is -15.30%.
What stocks does David Shook hold?
David Shook holds: LYEL, NKTX stocks.
What was David Shook’s latest transaction?
David Shook’s latest transaction was an Informative Sell of $6.35K.
What was David Shook's most profitable transaction?
David Shook’s most profitable transaction was an Informative Sell of NKTX stock on January 18, 2024. The return on the trade was 70.90%.
What is David Shook's role in Lyell Immunopharma?
David Shook's role in Lyell Immunopharma is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.